Ireland vs Serbia: Cause of death, by non-communicable diseases, ages 5-14
Ireland
70.3%
in 2021
Serbia
71.2%
in 2021
Ireland rank
10th
Serbia rank
7th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Ireland
- Serbia
How they compare
Serbia currently reports 71.2% against 70.3% in Ireland, a difference of 0.9%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Serbia ahead.
Ireland ranks 10th and Serbia ranks 7th of 185 countries.
Across the 3 decades both report, Ireland averaged higher in 1 and Serbia in 2.
Head to head by decade
| Decade | Ireland | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.1% | 49.3% | 0.1% | Serbia |
| 2010s | 74.1% | 62.1% | 12.0% | Ireland |
| 2020s | 66.3% | 70.5% | 4.2% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Ireland or Serbia?
- Serbia, at 71.2% against 70.3% in Ireland as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Ireland and Serbia?
- 0.9%, with Serbia ahead.
- How many years of comparable data are there for Ireland and Serbia?
- 6 years are reported by both, from 2000 to 2021.
- How do Ireland and Serbia rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Ireland ranks 10th and Serbia ranks 7th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.